Effect of the oral hypoglycemic agent, pirogliride, on gluconeogenesis.
D000227:Adenine Nucleotides / Q000494:pharmacology; D000818:Animals; D005943:Gluconeogenesis / Q000187:drug effects*; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007672:Kidney Cortex / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D008930:Mitochondria, Liver / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors
D000227:Adenine Nucleotides; D007004:Hypoglycemic Agents; D011759:Pyrrolidines; C021239:pirogliride